1. Home
  2. PTLE vs ALGS Comparison

PTLE vs ALGS Comparison

Compare PTLE & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PTLE

PTL LTD Ordinary Shares

HOLD

Current Price

$8.25

Market Cap

42.2M

Sector

Energy

ML Signal

HOLD

Logo Aligos Therapeutics Inc.

ALGS

Aligos Therapeutics Inc.

HOLD

Current Price

$8.74

Market Cap

40.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTLE
ALGS
Founded
2013
2018
Country
Singapore
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.2M
40.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PTLE
ALGS
Price
$8.25
$8.74
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$39.33
AVG Volume (30 Days)
531.4K
38.1K
Earning Date
05-15-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
88.30
EPS
N/A
N/A
Revenue
N/A
$2,186,000.00
Revenue This Year
N/A
$32.20
Revenue Next Year
N/A
$4.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.09
$4.20
52 Week High
$16.17
$13.69

Technical Indicators

Market Signals
Indicator
PTLE
ALGS
Relative Strength Index (RSI) 62.09 65.45
Support Level $0.14 $6.25
Resistance Level $12.45 $8.90
Average True Range (ATR) 0.93 0.64
MACD 0.12 0.15
Stochastic Oscillator 88.89 85.16

Price Performance

Historical Comparison
PTLE
ALGS

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, serving the Asia Pacific market. The company's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers on time; and handling disputes, mainly concerning quality and quantity issues on marine fuel. The company derives its maximum revenue from Hong Kong.

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Share on Social Networks: